Copyright
©The Author(s) 2024.
World J Clin Oncol. Aug 24, 2024; 15(8): 1048-1060
Published online Aug 24, 2024. doi: 10.5306/wjco.v15.i8.1048
Published online Aug 24, 2024. doi: 10.5306/wjco.v15.i8.1048
Neoplasm type | CeD cases | CeD controls | OR (95%CI) | P value |
Unweighted (n = 108052), 50%, n (%) | Unweighted (n = 108052), 50%, n (%) | |||
All malignant neoplasm | 15884 (14.70) | 14125 (13.07) | 1.15 (1.12-1.18) | < 0.0001 |
Positive association | ||||
Stomach | 179 (0.17) | 133 (0.12) | 1.35 (1.08-1.69) | 0.0092 |
Small intestine | 177 (0.16) | 23 (0.02) | 7.71 (5.0-11.9) | < 0.0001 |
Liver | 261 (0.24) | 143 (0.13) | 1.83 (1.49-2.24) | < 0.0001 |
Biliary | 90 (0.08) | 65 (0.06) | 1.39 (1.01-1.91) | 0.0446 |
Other GI organs | 87 (0.08) | 43 (0.04) | 2.02 (1.41-2.92) | < 0.0001 |
Thyroid | 474 (0.44) | 259 (0.24) | 1.84 (1.58-2.13) | < 0.0001 |
Pancreas | 358 (0.33) | 235 (0.22) | 1.53 (1.29-1.80) | < 0.0001 |
Melanoma skin | 552 (0.51) | 359 (0.33) | 1.54 (1.35-1.76) | < 0.0001 |
Nonmelanoma skin (all other skin excluding melanoma) | 1441 (1.33) | 735 (0.68) | 1.97 (1.81-2.16) | < 0.0001 |
Other neuroendocrine tumors | 74 (0.07) | 50 (0.05) | 1.48 (1.03-2.12) | 0.0311 |
Lymphoma | 1861 (1.72) | 912 (0.84) | 2.06 (1.90-2.23) | < 0.0001 |
Leukemia | 835 (0.77) | 742 (0.69) | 1.13 (1.02-1.25) | 0.0187 |
Myelodysplastic syndrome | 397 (0.37) | 216 (0.20) | 1.84 (1.55-2.17) | < 0.0001 |
Uterus | 562 (0.52) | 482 (0.45) | 1.17 (1.03-1.32) | 0.0131 |
Prostate | 1421 (1.32) | 1247 (1.15) | 1.14 (1.06-1.23) | 0.0007 |
Testis | 84 (0.08) | 56 (0.05) | 1.50 (1.07-2.10) | 0.0179 |
Negative association | ||||
Respiratory | 1244 (1.15) | 1813 (1.68) | 0.68 (0.63-0.73) | < 0.0001 |
Secondary malignancies | 2199 (2.04) | 2846 (2.63) | 0.76 (0.73-0.81) | < 0.0001 |
Urinary | 952 (0.88) | 1053 (0.97) | 0.90 (0.83-0.99) | 0.0234 |
Null association | ||||
Head and neck | 272 (0.25) | 314 (0.29) | 0.87 (0.74-1.02) | 0.0823 |
Nervous system | 227 (0.21) | 257 (0.24) | 0.88 (0.74-1.06) | 0.1722 |
Esophagus | 152 (0.14) | 125 (0.12) | 1.22 (0.96-1.54) | 0.1045 |
Colorectal | 1752 (1.62) | 1774 (1.64) | 0.99 (0.93-1.06) | 0.7087 |
Anus | 21 (0.02) | 26 (0.02) | 0.81 (0.45-1.44) | 0.4658 |
Breast | 2844 (2.63) | 2919 (2.70) | 0.98 (0.92-1.03) | 0.3166 |
Other endocrine (excluding thyroid and pancreas) | 25 (0.02) | 30 (0.03) | 0.83 (0.49-1.41) | 0.5001 |
Malignant carcinoid tumor - small intestine | 14 (0.01) | 13 (0.01) | 1.08 (0.51-2.29) | 0.8474 |
Malignant carcinoid tumor - large intestine | 5 (0.005) | 6 (0.005) | 0.83 (0.25-2.73) | 0.7630 |
Bone and connective tissues | 134 (0.12) | 161 (0.15) | 0.83 (0.66-1.04) | 0.1157 |
Myeloma | 313 (0.29) | 274 (0.25) | 1.14 (0.97-1.34) | 0.1070 |
Cervix | 448 (0.41) | 418 (0.39) | 1.07 (0.94-1.22) | 0.3070 |
Ovary | 472 (0.44) | 430 (0.40) | 1.10 (0.96-1.25) | 0.1611 |
Other female genital organs | 126 (0.12) | 139 (0.13) | 0.91 (0.71-1.15) | 0.4242 |
Other male genital organs | 11 (0.01) | 4 (0.004) | 2.75 (0.88-8.63) | 0.0707 |
- Citation: Haider MB, Al Sbihi A, Reddy SN, Green P. Prevalence of malignant neoplasms in celiac disease patients - a nationwide United States population-based study. World J Clin Oncol 2024; 15(8): 1048-1060
- URL: https://www.wjgnet.com/2218-4333/full/v15/i8/1048.htm
- DOI: https://dx.doi.org/10.5306/wjco.v15.i8.1048